Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05697861 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05697861 · ClinicalTrials.gov record · last posted 2026-08-03

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

Name: Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001 — clinical trial record (NCT05697861)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusEnrolling by Invitation

PhaseNot specified

SponsorIntellia Therapeutics

Started2023-07-10

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.

Protocol amendment history 1 change detected by DataLookout

2026-08-04

Trial status changed: Recruiting → Enrolling by Invitation

Trial Details

NCT Number	NCT05697861
Lead Sponsor	Intellia Therapeutics
Conditions	Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy, Wild-Type Transthyretin Cardiac Amyloidosis
Enrollment	72 participants
Start Date	2023-07-10
Primary Completion	2038-03 (estimated)
Study Completion	2038-03 (estimated)
Updated on ClinicalTrials.gov	2026-08-03